| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0096 | 0.8 |